Skip to main content

Microtiter plate assays, a high throughput solution

The microtiter plate is a standard tool in analytical research and diagnostic testing laboratories. SphingoTec’s microtiter plate assays are based on a chemiluminescence sandwich immunoassay technology and allow the measurement of SphingoTec’s proprietary biomarkers Proenkephalin A 119-159 (penKid) and bioactive Adrenomedullin 1-52 (bio-ADM). They are available as CE IVD microtiter plate assays. In addition, SphingoTec offers CE IVD microtiter plate assays for the novel biomarker Dipeptidyl Peptidase 3 (DPP3).

EDTA plasma

sphingotest® microtiter plate assay requires EDTA plasma

1h incubation

Following a 30 minutes hands-on time, the assay incubates for 1 hour

High throughput

One test kit contains enough reagent to run 41 samples in double determinations

Microtiter plate assays

SphingoTec develops and markets innovative in vitro diagnostic (IVD) tests for novel and proprietary biomarkers. IVD tests for SphingoTec’s proprietary biomarkers are made available as sphingotest® microtiter plate tests. 

Critical care diagnostics

sphingotest® bio-ADM®

The sphingotest® bio-ADM® is an immunoluminometric assay (ILMA) for the in vitro diagnostic quantitative measurement of bioactive Adrenomedullin 1-52 in human EDTA plasma. In conjunction with clinical assessments the test results are used as an aid in the prediction of the need of vasopressor therapy in patients with sepsis or septic shock.

Understanding bioactive Adrenomedullin 1-52

sphingotest® penKid®

The sphingotest® penKid® is an immunoluminometric assay (ILMA) for the determination of Proenkephalin A 119-159 in human EDTA plasma. In conjunction with clinical assessments, the test results are used as an aid in the diagnosis of acute kidney injury in adult patients with sepsis or septic shock.

Understanding Proenkephalin A 119-159

sphingotest® DPP3

The sphingotest® DPP3 is an immunoluminometric assay (ILMA) for the determination of Dipeptidyl Peptidase 3 in human EDTA plasma. In conjunction with clinical assessments, the test results are used as an aid in the prediction of short-term survival in patients with sepsis or septic shock.

Understanding Dipeptidyl Peptidase 3

 

Contact us

Do you have any questions or require more information? Please do not hesitate to contact us if you are interested in our products or need support. We are looking forward to talking to you!

mobile: +49 (0)1520 7590 783
email: karolina.szczesna[at]sphingotec.com

Dr. Karolina Szczesna-Brost

Head of Product Management